We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Glyburide vs Insulin and Adverse Pregnancy Outcomes

Maisa N. Feghali, MD1; Christina M. Scifres, MD2; Steve N. Caritis, MD1
[+] Author Affiliations
1Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
2Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City
JAMA Pediatr. 2015;169(10):974. doi:10.1001/jamapediatrics.2015.1805.
Text Size: A A A
Published online


To the Editor The increasing prevalence of gestational diabetes (GDM) and the surge in glyburide use for the treatment of GDM highlight the need for continued research within this area, and we therefore read the article by Camelo Castillo et al1 titled “Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women with Gestational Diabetes” and the accompanying editorial2 with great interest. The results of this study are thought provoking, but we are concerned that the limitations of their study design preclude attribution of the increased risk for neonatal intensive care unit admission, respiratory distress syndrome, and large for gestational age to glyburide use. While glyburide remains one possible cause of increased neonatal risks, both maternal obesity and gestational age at delivery are important potential confounding variables. Although the authors provide one reference for the sensitivity of International Classification of Diseases, Ninth Revision codes for obesity in pregnancy, others have found even lower sensitivities for the diagnosis of obesity3 and we are concerned that obesity may not have been adequately accounted for in their analyses. In addition, even among term gestations the risk for neonatal morbidity varies greatly by gestational age, so the lack of information regarding gestational age at delivery is significant.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





October 1, 2015
Wendy Camelo Castillo, MD, PhD; Michele Jonsson Funk, PhD
1Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore
2Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill
JAMA Pediatr. 2015;169(10):975. doi:10.1001/jamapediatrics.2015.1811.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...